transgenic model visceral obesity metabolic syndrome
adverse metabolic consequences obesity best predicted quantity visceral fat excess glucocorticoids produce visceral obesity diabetes circulating glucocorticoid levels normal typical obesity glucocorticoids can produced locally inactive keto forms enzyme beta hydroxysteroid dehydrogenase type beta hsd- created transgenic mice overexpressing beta hsd selectively adipose tissue extent similar found adipose tissue obese humans mice increased adipose levels corticosterone developed visceral obesity exaggerated high-fat diet mice also exhibited pronounced insulin-resistant diabetes hyperlipidemia surprisingly hyperphagia despite hyperleptinemia increased adipocyte beta hsd activity may common molecular etiology visceral obesity metabolic syndrome
